Lyon Joseph Douglasinsider trades
In SEC Form 4 filings, Lyon Joseph Douglas is listed as See Remarks of Corcept Therapeutics Inc (CORT). In the last 90 days, Lyon Joseph Douglas sold $2.30M of Corcept Therapeutics Inc (CORT) on the open market and bought none. All 5 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| CORTCorcept Therapeutics Inc | See Remarks | 18 | Oct 5 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-03
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| CORTCorcept Therapeutics Inc | Oct 2 | Oct 5 | M | 3,357 | $13.56 | $45,521 | 9,040 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Oct 2 | Oct 5 | M | 5,833 | $19.26 | $112,344 | 14,873 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Oct 2 | Oct 5 | S | 4,446 | $115.70 | Sale −$514,389 | 10,427 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Oct 2 | Oct 5 | S | 4,744 | $116.54 | Sale −$552,869 | 5,683 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Oct 2 | Oct 5 | M · derivative | 3,357 | $13.56 | $45,521 | not reported | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Oct 2 | Oct 5 | M · derivative | 5,833 | $19.26 | $112,344 | 44,167 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Oct 1 | Oct 5 | M | 810 | $13.56 | $10,984 | 6,493 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Oct 1 | Oct 5 | S | 810 | $115.40 | Sale −$93,473 | 5,683 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Oct 1 | Oct 5 | M · derivative | 810 | $13.56 | $10,984 | 3,357 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Sep 14 | Sep 16 | M | 2,596 | $11.35 | $29,465 | 8,279 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Sep 14 | Sep 16 | M | 7,404 | $13.56 | $100,398 | 15,683 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Sep 14 | Sep 16 | S | 7,812 | $113.32 | Sale −$885,261 | 7,871 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Sep 14 | Sep 16 | S | 2,188 | $114.12 | Sale −$249,686 | 5,683 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Sep 14 | Sep 16 | M · derivative | 2,596 | $11.35 | $29,465 | not reported | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Sep 14 | Sep 16 | M · derivative | 7,404 | $13.56 | $100,398 | 4,167 | Yes | Form 4 |
| CORTCorcept Therapeutics Inc | Sep 2 | Sep 3 | F | 72 | $113.38 | $8,163 | 5,683 | No | Form 4 |
| CORTCorcept Therapeutics Inc | Sep 1 | Sep 3 | A | 130 | $113.38 | $14,739 | 5,625 | No | Form 4 |
| CORTCorcept Therapeutics Inc | Sep 1 | Sep 3 | A | 130 | $0.00 | $0 | 5,755 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.